NDC 72205-205

ziprasidone mesylate

Ziprasidone Mesylate

ziprasidone mesylate is a Intramuscular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Novadoz Pharmaceuticals Llc. The primary component is Ziprasidone Mesylate.

Product ID72205-205_90b35a26-ab65-4c39-b97f-55c8c0e34b0b
Product TypeHuman Prescription Drug
Proprietary Nameziprasidone mesylate
Generic NameZiprasidone Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-09-15
Marketing CategoryANDA /
Application NumberANDA216091
Labeler NameNovadoz Pharmaceuticals LLC
Active Ingredient Strength20 mg/mL
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31


NDC 72205-205-07

10 VIAL, SINGLE-DOSE in 1 CARTON (72205-205-07) > 1 mL in 1 VIAL, SINGLE-DOSE (72205-205-01)
Marketing Start Date2022-09-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ziprasidone mesylate" or generic name "Ziprasidone Mesylate"

NDCBrand NameGeneric Name
43598-061ziprasidone mesylateziprasidone mesylate
43598-848ziprasidone mesylateziprasidone mesylate
68083-340ziprasidone mesylateziprasidone mesylate
72205-205ziprasidone mesylateziprasidone mesylate
72266-160ziprasidone mesylateziprasidone mesylate
0049-1203Geodonziprasidone mesylate
0049-3920Geodonziprasidone mesylate
50090-4540Geodonziprasidone mesylate
64725-3920Geodonziprasidone mesylate

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.